Compare SMTI & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | INGN |
|---|---|---|
| Founded | 1982 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.9M | 186.8M |
| IPO Year | N/A | 2014 |
| Metric | SMTI | INGN |
|---|---|---|
| Price | $24.22 | $6.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $41.00 | $11.00 |
| AVG Volume (30 Days) | 43.0K | ★ 149.6K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $101,877,532.00 | ★ $347,028,000.00 |
| Revenue This Year | $21.60 | $8.04 |
| Revenue Next Year | $16.70 | $8.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.52 | 4.68 |
| 52 Week Low | $18.90 | $5.70 |
| 52 Week High | $38.68 | $12.91 |
| Indicator | SMTI | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.89 | 44.42 |
| Support Level | $24.00 | $6.62 |
| Resistance Level | $25.41 | $7.01 |
| Average True Range (ATR) | 1.18 | 0.19 |
| MACD | 0.26 | 0.02 |
| Stochastic Oscillator | 44.86 | 35.35 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.